Since recent studies showed that PAB ameliorates atherosclerosis progression by blocking NF‐κB activation,19 we hypothesised that PAB regulates OA progression and synovial inflammation by targeting NF‐κB signalling. The gene discussed is NFKB1; the disease is atherosclerosis.